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Dexmedetomidine-based Awake-Asleep-Awake Technique in Prone Position for a Morbidly Obese Patient  
with Obstructive Sleep Apnea for Spinal Cord Stimulator Implantation 
 
Stanlies D’Souza, MD 
 
Department of Anesthesiology at Baystate Medical Center / University of Massachusetts Medical School 
CONCLUSION 
 
Our dexmedetomidine-propofol combined technique did not produce any 
hypoxic events during the above procedure. Patient effectively 
participated in the trial with a high level of cooperation. We recommend 
this technique for morbidly obese patients in prone position for spinal 
cord stimulation trial. Its  opiate-sparing effects and lack of respiratory 
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Our Novel Anesthesia technique for Awake-Asleep- Awake  technique 
for  this  morbidly obese patient with Obstructive Sleep Apnea for Spinal 
Cord Stimulator Implantation 
1. Administer preoperative  acetaminophen 
2. Position patient awake in comfortable prone position 
3. Dexmedetomidine 1mcg/kg  bolus over 10 min followed by 0.2-0.7 mcg/kg/hr 
of infusion 
4. Add propofol at 100 mcg/kg/min and reduce the infusion rate as the patient 
falls asleep 
5. Remifentanil at 0.01-0.05 mcg/kg/min 
6. Use lean body weight for dosing propofol/dexmedetomidine/opiates 
7. Avoid using midazolam 
8. Stop infusions at least 10-15 min prior to proposed wake up 
9. Continue oxygen via face mask or nasal cannula 
10. Use high flow oxygen when the patient is asleep, which improves oxygenation during apneic episodes. 
Introduction 
  
Morbidly obese patients in a prone 
position are at high risk for airway 
obstruction and hypoxic episodes. 
Dexmedetomidine reduces the 
amount of propofol needed and the 
incidence of such hypoxic episodes. 
Recent evidence shows that 
dexmedetomidine-based total 
intravenous anesthesia (TIVA) 
results in less apnea and 
desaturation compared to propofol-
based TIVA techniques and is better 
tolerated in morbidly obese patients. 
 
Case Description 
A 42-year-old male with a BMI of 51 
and a history of obstructive sleep 
apnea (OSA) presented for spinal 
cord implantation for chronic back 
pain. Dexmedetomidine 1 mcg/kg 
bolus followed by 0.5-0.7 
mcg/kg/hour infusion was combined 
with low dose of propofol and 
remifentanil infusion. The lean body 
weight was used for anesthetic drug 
administration. Patient saturated at 
100% throughout the procedure with 
supplemental oxygen and no apnea 
episodes.. 
 
Properties of Dexmedetomidine: 
 
1. Dexmedetomidine Is an alpha 2 agonist and 
acts at presynaptic level 
2. It reduces the release of norepinephrine 
3. Alpha 2 receptors are centrally located 
locus coeruleus 
4. It causes minimal respiratory depression 
5. It causes more bradycardia and less 
hypotension than clonidine 
6. It produces alpha waves on EEG; does not 
produce delta waves or burst suppression; 
EEG resembles normal stage 2 sleep 
7. It reduces emergence agitation 
8. It has analgesic properties 
 
STOP BANG criteria for 
identifying Obstructive Sleep 
Apnea (OSA)1 
 
The presence of three or more 
factors increases the risk of OSA. 
 
1.  Male 
2.  Age over 50 
3.  Hypertension 
4.  Neck circumference 
more than 40 cm 
5.  History of snoring 






Patients with sleep apnea are at high risk for respiratory depression caused by sedatives, 
opiates and hypnotic agents.   OSA is usually confirmed with polysomnography.  
Identifying OSA suspects using STOP BANG criteria during preoperative evaluation is 
essential in planning the Monitored Anesthesia care technique for an obese patient. 
